Trial Condition(s):

Pneumonia

Community-Acquired Pneumonia (CAP) surveillance

Bayer Identifier:

15465

ClinicalTrials.gov Identifier:

NCT01416506

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Prospective, non-interventional, multi-center study. 7 investigative centers will involved in China. Around 560 CAP outpatients or inpatients will be screened until 56 M. pneumoniae isolates collected.

Inclusion Criteria
- Chinese adult (male or female) ≥18 years old
 - Outpatients or inpatients who suffer from CAP
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
560
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
No Drug
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, China

Status
Completed
 

Trial Design